New England Biolabs
New England Biolabs is a privately held enzyme and reagent manufacturer, founded in 1974 and headquartered in Ipswich, MA, that supplies molecular biology tools to academic researchers, molecular diagnostics developers, and biopharmaceutical companies worldwide through 11 country subsidiaries and a direct e-commerce platform.
- Company typePrivate
- Founded1974
- HeadquartersIpswich, United States
- Headcount501–1,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What New England Biolabs does
New England Biolabs (NEB), founded in 1974 and headquartered in Ipswich, Massachusetts, is a privately held manufacturer of molecular biology enzymes and reagents serving academic, government, molecular diagnostics, and biopharmaceutical customers across more than 11 countries through wholly-owned subsidiaries and regional distributors. The company's product portfolio spans restriction endonucleases, DNA and RNA polymerases, nucleic acid purification kits, isothermal amplification enzymes, NGS library preparation reagents, DNA assembly systems, CRISPR/Cas tools, and cell-free protein synthesis kits, organized around flagship brands including NEBNext, Q5, Luna, Monarch, NEBuilder, NEBridge, WarmStart, OneTaq, and the recently launched EnClose cell-free dbDNA synthesis kit. Core technology is grounded in 50+ years of proprietary enzyme engineering, including ultra-high-fidelity polymerases claimed at ~280x Taq fidelity, aptamer-inhibited WarmStart isothermal enzymes, and Type IIS-based Golden Gate and HiFi DNA assembly platforms.
NEB makes money through three primary streams: catalog research reagents and kits sold one-time via direct e-commerce and distributor channels (with free shipping over $450), custom manufacturing services including GMP-grade production and lyophilization through its Customized Solutions group (active for over 30 years), and OEM/bulk reagent supply to diagnostic kit manufacturers. Customer-facing reach is built on a hybrid direct-to-consumer e-commerce platform (neb.com) and local sales/technical support through subsidiaries in the US, Australia, Canada, China, France, Germany, India (opened March 2026), Japan, New Zealand, Singapore, South Korea, and the UK, complemented by five leading automation-vendor integrations (Hamilton, Revvity, SPT Labtech, Beckman Coulter Genomics, Eppendorf) for NEBNext NGS workflows.
Strategically, NEB has shifted from a horizontal academic reagent supplier toward higher-value regulated and therapeutic-adjacent markets: lyophilization for point-of-care diagnostics (Fluorogenics acquisition, 2021), cell-free dbDNA for nucleic acid manufacturing (Touchlight partnership, 2026), synthetic bacteriophage engineering (Yale, 2026), epigenomics (EpiCypher, 2026), and global zoonotic pathogen surveillance (Johns Hopkins APL, 2025). NEB holds ISO certification, B Corporation status, and is led by CEO James Ellard with Founder Donald Comb as Chairman and Nobel Laureate Richard Roberts as CSO.
New England Biolabs firmographics
Firmographics- Name
- New England Biolabs
- Legal name
- New England Biolabs, Inc.
- Website
- https://neb.com
- Company type
- Private
- Founded year
- 1974
- Operating status
- Operating
- Headcount range
- 501–1,000 employees
- Short description
- New England Biolabs is a privately held enzyme and reagent manufacturer, founded in 1974 and headquartered in Ipswich, MA, that supplies molecular biology tools to academic researchers, molecular diagnostics developers, and biopharmaceutical companies worldwide through 11 country subsidiaries and a direct e-commerce platform.
- Ownership category
- akta.pro rank
New England Biolabs industry classification
Industry- Product category
- Life Science Reagents
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Laboratory Analytical Instruments (3826), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays) (HLAGAIAF)
- akta.pro secondary industries
- mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA) (HLAGAGAC), Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI), Synthetic Biology & Genetic Circuit Design Platforms (pathway engineering, chassis development) (HLAAAIAD)
Keywords
Where New England Biolabs is headquartered
LocationHeadquarters
- HQ city
- Ipswich
- HQ country
- United States
- HQ region
- North America
Offices12 records
Markets served
New England Biolabs business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Research Reagents and Kits: Sale of molecular biology reagents including restriction enzymes, polymerases, PCR/qPCR reagents, NGS library prep kits, DNA assembly reagents, and nucleic acid purification products to research institutions, pharmaceutical companies, and biotech firms. Products sold in standard catalog formats and bulk/custom configurations.
- Custom Manufacturing Services: GMP-grade product manufacturing, lyophilization services, and custom formulation services for diagnostic and therapeutic developers requiring specialized reagent formats. NEB's Customized Solutions group serves customers for over 30 years with scale-up and manufacturing capabilities.
- OEM and Bulk Reagents: Bulk and custom-format reagents for diagnostic kit manufacturers and other industrial customers requiring large-volume reagent supply.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels9 records
New England Biolabs product offering
Product offeringCore offering
New England Biolabs manufactures and sells recombinant and native enzymes, reagents, and kits for molecular biology research, genomics, diagnostics, and biotherapeutic development. The product catalog spans restriction endonucleases, high-fidelity polymerases, qPCR master mixes, NGS library preparation reagents, nucleic acid purification kits, DNA assembly systems, isothermal amplification enzymes, and cell-free protein synthesis tools. NEB also provides custom manufacturing services including GMP-grade production and lyophilization for diagnostic and therapeutic developers.
Product overview
New England Biolabs (NEB) offers a comprehensive portfolio of molecular biology reagents organized around several core product lines. The main offerings include NEBNext for next-generation sequencing library preparation (featuring DNA/RNA library prep kits, UltraShear fragmentation enzymes, Enzymatic Methyl-seq, and multiplex oligos), Monarch for nucleic acid purification (spin column and magnetic bead-based kits for gDNA, plasmid, viral DNA/RNA, cfDNA, and RNA), Luna for qPCR/RT-qPCR (with warm-start dye-based and probe-based options), and Q5 for high-fidelity PCR (~280x Taq fidelity). Key DNA assembly products include NEBuilder HiFi DNA Assembly and NEBridge Golden Gate Assembly for seamless multi-fragment cloning. NEB also provides specialized enzymes including WarmStart LAMP/RT-LAMP for isothermal amplification, CRISPR/Cas gene editing tools, PURExpress cell-free protein synthesis, RNA synthesis/modification enzymes, and over 400 restriction endonucleases. Recent additions include the EnClose Cell-free dbDNA Synthesis Kit (with Touchlight) for rapid mRNA vaccine development and Monarch Mag magnetic bead purification kits. The company also offers custom manufacturing including lyophilization services and GMP-grade production. Products are available through global subsidiaries and distributors.
Differentiator
Problem solved
Functional benefit
Brands
- NEBNext: Next Generation Sequencing library preparation products
- Monarch
- NEBuilder
- Luna
- Q5
- EnClose
- NEBridge
- OneTaq
- WarmStart
- LyoPrime
Products and services
- NEBNext (Next Generation Sequencing Library Preparation) Comprehensive portfolio of reagents for next-generation sequencing library preparation, including DNA/RNA library prep kits, ultra-shear fragmentation enzymes, methyl-seq kits, multiplex oligos, and components for various sequencing platforms (Illumina, Oxford Nanopore, Ion Torrent).
- Monarch (Nucleic Acid Purification) Complete line of nucleic acid purification kits including spin column and magnetic bead-based workflows for genomic DNA, plasmid, viral DNA/RNA, cell-free DNA, and RNA extraction with high purity and yield.
- Luna (qPCR/RT-qPCR) Luna family of quantitative PCR and reverse transcription qPCR reagents featuring warm-start technology for improved specificity, with options for dye-based and probe-based detection formats.
- Q5 (High-Fidelity DNA Polymerase) Ultra high-fidelity DNA polymerases offering approximately 280 times the fidelity of Taq polymerase, with hot-start versions for robust performance on diverse templates including high-AT and high-GC targets.
- NEBuilder HiFi DNA Assembly DNA assembly cloning system that reliably joins multiple DNA fragments in a single tube via isothermal reaction, suitable for seamless cloning and multi-fragment assembly.
- NEBridge Golden Gate Assembly Modular DNA assembly system utilizing type IIS restriction enzymes for seamless, scarless joining of multiple DNA fragments with built-in flexibility for diverse assembly designs.
- EnClose Cell-free dbDNA Synthesis Kit Rapid enzymatic production kit for doggybone DNA (dbDNA), a closed-ended DNA format lacking bacterial sequences. Enables cell-free synthesis of DNA for mRNA vaccines and gene therapies in a single-day workflow.
- WarmStart LAMP/RT-LAMP Kits Loop-mediated isothermal amplification kits with warm-start technology for room temperature reaction setup, enabling rapid nucleic acid amplification without thermocycling for point-of-care diagnostics.
- Competent Cells E. coli competent cell strains including NEB 5-alpha, NEB 10-beta, NEB Turbo, and specialized strains for cloning, subcloning, and protein expression with various efficiency levels.
- Restriction Endonucleases Over 400 restriction enzymes including Type II enzymes with HF (high-fidelity) variants, with detailed specificities and performance information in the REBASE database.
- Enzymatic Methyl-seq (EM-seq) Enzymatic approach to DNA methylation sequencing that protects DNA from damage while converting unmethylated cytosines for detection, as an alternative to bisulfite conversion.
- RNA Synthesis and Modification Enzymes Enzymes for RNA research including reverse transcriptases, RNA ligases, RNase inhibitors, and in vitro transcription enzymes for mRNA synthesis workflows.
- CRISPR/Cas Gene Editing Cas nucleases including Spy Cas9, SpRY, and associated reagents for genome editing experiments, with tools for guide RNA design and genome targeting efficiency assessment.
- PURExpress In Vitro Protein Synthesis Cell-free protein synthesis kit based on E. coli cell extract, enabling rapid protein expression without living cells for protein characterization and optimization.
- DNA/RNA Markers and Ladders Molecular weight markers and DNA ladders for accurate sizing of DNA fragments in gel electrophoresis applications, including 1 kb, 100 bp, and specialized ladders.
- GMP-grade Custom Manufacturing Services GMP-grade product manufacturing and custom formulation services for diagnostic and therapeutic developers requiring specialized reagent formats and scalable production.
- Lyophilization Solutions Freeze-dried and lyo-compatible reagent formulations and lyophilization R&D services for ambient storage and simplified shipping, supporting molecular diagnostics development with extended stability.
- OEM and Bulk Reagents Bulk and custom-format reagents for diagnostic kit manufacturers and other industrial customers requiring large-volume reagent supply.
Quantifiable outcome
- Q5 High-Fidelity DNA Polymerase provides approximately 280X fidelity of Taq polymerase
- +2 more outcomes
Companies that use New England Biolabs
Customer profileNamed customers6 records
Segments5 records
Ideal customer profiles4 records
New England Biolabs technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration6 records
Feature8 records
New England Biolabs partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- EpiCyphercoreExpanded strategic partnership to develop epigenomics research tools. Building on prior collaboration, the partnership focuses on creating innovative technologies for gene regulation, chromatin biology, and disease mechanisms, with NEB distributing EpiCypher's genomic products in international markets.
- TouchlightcoreJoint development of EnClose Cell-free dbDNA Synthesis Kit enabling benchtop enzymatic synthesis of Touchlight's proprietary doggybone DNA (dbDNA) for nucleic acid therapeutic development. Combines Touchlight's DNA technology with NEB's expertise in enzymology for an optimized workflow suitable for viral vector manufacturing and nucleic acid therapeutics.
- Laboratory Automation Providers (Hamilton Company, Revvity, SPT Labtech, Beckman Coulter Genomics, Eppendorf)coreCollaborations with five leading automation providers to support automated next-generation sequencing library preparation using NEBNext reagents. Partnerships focus on standardizing, optimizing, and verifying automated workflows across NEB's product portfolio for global deployment with reduced customer validation burden.
- Yale UniversitycoreCollaboration to develop the first fully synthetic bacteriophage engineering system using NEB's High-Complexity Golden Gate Assembly platform. Scientists from NEB and Yale created a system to construct and reprogram bacteriophages from digital sequence data, enabling accelerated discovery of bacteriophage-based therapeutics.
- Johns Hopkins Applied Physics LaboratoryminorCollaboration to develop the NEBNext Flu A Integrated Indexing Primer Module for high-throughput sequencing of Influenza A virus using Oxford Nanopore Technologies platforms. Aims to enhance global health response capabilities through quicker genomic analysis of zoonotic pathogens.
- Fluorogenics Limited (FGL)coreNEB acquired UK-based Fluorogenics Limited, a lyophilization R&D service company, to expand capabilities in lyophilized reagents for molecular diagnostics, especially for point-of-care applications. FGL operates as a wholly-owned subsidiary of NEB with existing operations continuing without disruption.
- International Centre for Genetic Engineering and Biotechnology (ICGEB)corePartnership in the EXPANDIA project coordinated by ICGEB to validate RT-LAMP technology as a cost-effective diagnostic alternative to PCR for COVID-19 testing in low-resource settings across multiple African nations and Italy. Project tested approximately 4,200 samples achieving sensitivity rates up to 90%.
Scale indicators5 records
Recent moves7 records
Expansion highlights5 records
New England Biolabs competitors and assessment
Company assessmentBroad incumbents
- Thermo Fisher Scientific: Largest life science tools company offering molecular biology reagents, enzymes, and kits across its Invitrogen and Applied Biosystems brands. Overlaps NEB on polymerases, restriction enzymes, and nucleic acid purification but offers a far broader portfolio anchored by instruments and consumables.
- Bio-Rad Laboratories: Diversified life science research and clinical diagnostics company offering PCR enzymes, digital PCR, and protein tools. Overlaps with NEB in PCR reagents and protein expression, while also serving adjacent markets like clinical diagnostics.
- Agilent Technologies: Major life science and analytical instruments company providing genomics, PCR/qPCR, and cell analysis reagents. Competitor in molecular biology tools, particularly in NGS library prep (SureSelect) and qPCR reagents where NEB also competes.
- Merck KGaA (Sigma-Aldrich / MilliporeSigma Life Science): Global life science tools supplier offering enzymes, buffers, and nucleic acid reagents under the Sigma-Aldrich brand. Competes with NEB across research reagents with a much larger catalog and distribution footprint.
Direct peers
- Promega Corporation: Privately held molecular biology reagent manufacturer serving research, diagnostics, and applied markets with enzymes, PCR/qPCR kits, and nucleic acid purification. Closest direct competitor to NEB in business model and customer base, with comparable focus on customer-centric service.
- Qiagen: Provider of sample preparation, PCR/qPCR, and NGS library prep reagents under brands such as QIAamp and QIAseq. Directly competes with NEBNext and Monarch kits in nucleic acid extraction and sequencing workflows, with deeper presence in molecular diagnostics.
- Takara Bio: Japan-based molecular biology and cell therapy tools provider offering PCR enzymes, NGS library prep (SMARTer), and gene therapy reagents. Directly competes with NEB in PCR and NGS, particularly in Asia-Pacific markets where NEB also operates subsidiaries.
Others
- Illumina: Dominant NGS sequencing platform vendor that consumes third-party library prep reagents including NEBNext. Adjacent peer rather than direct competitor — NEB supplies into the Illumina ecosystem via co-validated workflows, making Illumina a key channel partner as well as a competitive force when it bundles proprietary reagents.
Emerging players
- Zymo Research: Privately held nucleic acid purification and epigenetics reagent provider competing directly with NEB's Monarch line and EM-seq kits. Smaller scale but growing aggressively in the same molecular biology workflow niches.
- Codexis: Protein engineering platform company developing engineered enzymes for therapeutics manufacturing and life science applications. Comparable to NEB's enzyme engineering capabilities but oriented toward licensing and biopharma partnerships rather than catalog reagent sales.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
New England Biolabs social profiles
Digital presenceNew England Biolabs compliance and trust
Trust signalCompliance1 record
New England Biolabs financial estimates
Financial estimateRevenue estimate
Valuation estimate
New England Biolabs leadership team
Management profileNumber of profiles
Profiles6 records
New England Biolabs subsidiaries and ownership
Company hierarchySubsidiaries12 records
New England Biolabs funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
New England Biolabs M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about New England Biolabs
What does New England Biolabs do?
New England Biolabs manufactures and sells recombinant and native enzymes, reagents, and kits for molecular biology research, genomics, diagnostics, and biotherapeutic development. The product catalog spans restriction endonucleases, high-fidelity polymerases, qPCR master mixes, NGS library preparation reagents, nucleic acid purification kits, DNA assembly systems, isothermal amplification enzymes, and cell-free protein synthesis tools. NEB also provides custom manufacturing services including GMP-grade production and lyophilization for diagnostic and therapeutic developers.
Is New England Biolabs a public or private company?
New England Biolabs is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was New England Biolabs founded?
New England Biolabs was founded in 1974. It employs 501 to 1,000 people.
Where is New England Biolabs based?
New England Biolabs is headquartered in Ipswich, United States, in the North America region.
How does New England Biolabs make money?
Three revenue lines are on record. Research Reagents and Kits are the primary driver. The others are custom Manufacturing Services and OEM and Bulk Reagents.
Who are New England Biolabs's main competitors?
Broad incumbents on record are Thermo Fisher Scientific, Bio-Rad Laboratories, Agilent Technologies and Merck KGaA (Sigma-Aldrich / MilliporeSigma Life Science). Direct peers are Promega Corporation, Qiagen and Takara Bio. Illumina is listed as an others. Emerging players are Zymo Research and Codexis.
Does New England Biolabs have an API?
No public API is recorded for New England Biolabs.
What industry is New England Biolabs in?
New England Biolabs's product category is Life Science Reagents. Its primary akta.pro industry code is HLAGAIAF, Molecular Biology & Genomics Instruments (PCR/qPCR, Sequencing, Microarrays), with a secondary code of HLAGAGAC, mRNA & Nucleic Acid Manufacturing Services (mRNA/saRNA/Plasmid DNA). Its NAICS code is 325414 and its SIC code is 3826.